Also, rarely is it the case that such expensive treatments are needed by more than a fraction of the population. I’d say there’s an argument to be made that we all aught to be okay with a small fraction of people getting healthcare that far outstrips their contribution via taxes – given that we never know if that one day may be us.
Yes, but that still must have limits. Society certainly should not pay one trillion dollars to care for a single patient. That’s too inefficient.
> then why shouldn't we?
Ultimately, there's only so much economy to go around. What percentage of it are you willing to dedicate to treating that one condition? What about everything that can't be funded as a result of that allocation?
But that is the purpose of high deductible health plans, to give healthcare recipients an incentive to to visit cheaper healthcare providers or accept generic medicines.
I emotionally agree with this, but I don't have a good answer for the following situation:
1) A company develops a new, slightly more efficacious treatment, patents it, and prices it at some completely absurd cost (say, $1 million/month for daily pills).
2) Doctors understandably prescribe this treatment because it's slightly more efficacious than the pills that cost $16/month.
Where would pricing pressure come into play here? If insurance companies can't say "No, that price is ridiculous and we're not paying it." I'm honestly wondering what the solution for this would be.